Associate Professor of Urology (Clinical Scholar) Director of Urologic Oncology
Urology
Dr. Siamak Daneshmand, MD
|
|
Give Review
Dr. Siamak Daneshmand is an expert in the field of Urology. He attended University of California Davis School of Medicine. University of California Davis School of Medicine has a rank of 43 in research and a 19 in primary care He over the years received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors:LA Area", "Top Doctors:Southern California" and "Super Doctor". Dr. Siamak Daneshmand is also a published physician. He has 95 paper published. The most recent paper is: Final Pathologic Stage after Neoadjuvant Chemotherapy and Radical Cystectomy For Bladder Cancer: Does pT0 Predict Better Survival Than pTa/Tis/T1? He accepts all Medicare patients.
Publications
- Utility and significance of ureteric frozen section analysis during radical cystectomy.
- Robotic Intracorporeal Orthotopic NeoBladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life.
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
- Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway.
- Orthotopic Urinary diversion.
- Urinary diversion 2015: controversies and new technologies: Choosing the 'right' diversion.
- Final Pathologic Stage after Neoadjuvant Chemotherapy and Radical Cystectomy For Bladder Cancer: Does pT0 Predict Better Survival Than pTa/Tis/T1?
- Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors.
- Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes.
- Cardiopulmonary bypass (CPB) has no significant impact on survival in patients undergoing nephrectomy and level III-IV inferior vena cava thrombectomy; a multi-institu...
- Impact of synchronous metastasis distribution on Cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
- Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events.
- Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.
- Urothelial carcinoma in Bladder diverticula: outcomes after radical cystectomy.
- Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk Bladder cancer.
- Radical Cystectomy with Super-extended Lymphadenectomy: Impact of Separate Versus en Bloc Lymph Node Submission on Analysis and Outcomes.
- Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy.
- Significance of perivesical lymph nodes in radical cystectomy for Bladder cancer.
- Validation of Surveillance, Epidemiology, and End Results TNM staging for Testicular germ cell tumor.
- A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts Bladder cancer recurrence.
- Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-term Experience with Intrapericardial Control.
- Reply by Author.
- Precystectomy serum levels of carbohydrate Antigen 19-9, carbohydrate Antigen 125, and carcinoembryonic Antigen: Prognostic value in invasive urothelial carcinoma of t...
- Mesenteric lymphadenopathy in Testicular germ cell tumor.
- Enhanced Recovery after Surgery in Patients Undergoing Radical Cystectomy for Bladder Cancer.
- Reprogramming of the intestinal epigenome by surgical tissue transposition.
- Urinary functional outcomes in female neoBladder patients.
- Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive Bladder cancer: Results from a prospective l...
- Urinary diversion after radical cystectomy for Bladder cancer: options, patient selection, and outcomes.
- Enhanced recovery pathway following radical cystectomy.
- Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the Bladder.
- Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial Bladder carcinoma: Oncological outcomes.
- Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the Bladder: A critical analysis of 1,994 patients.
- Outcome with Radical Cystectomy and Extended Lymphadenectomy Alone in Lymph Node Positive Bladder Cancer Patients Unfit for or Declining Adjuvant Chemotherapy.
- Active surveillance is the preferred approach to clinical stage I testicular Cancer.
- Long-term Cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate Cancer in the prostate-specific antigen era(☆)
- Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
- Refining Patient Selection for Neoadjuvant Chemotherapy Prior to Radical Cystectomy.
- The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing ra...
- Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus.
- Contemporary Management of Postchemotherapy Testis Cancer.
- Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
- Determining the Role of Cystectomy for High-grade T1 Urothelial Carcinoma.
- Does presence of squamous and glandular differentiation in urothelial carcinoma of the Bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
- Conversion From Incontinent Conduit to Continent Cutaneous Reservoir After Renal Transplant.
- Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the Bladder following partial cystectomy.
- Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
- Cryptorchidism and Testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by c...
- Editorial Comments.
- Androgen deprivation therapy: evidence-based management of side effects.
- Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial Bladder cancer.
- Urinary functional outcome following radical cystoprostatectomy and ileal neoBladder reconstruction in male patients.
- Minimally Invasive Postchemotherapy Retroperitoneal Lymph Node Dissection: Caution and Prudence.
- Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the Bladder: A retro...
- Preoperative Staging of Invasive Bladder Cancer With Dynamic Gadolinium-enhanced Magnetic Resonance Imaging: Results From a Prospective Study.
- Midline Extraperitoneal Approach for Retroperitoneal Lymph Node Dissection for Testicular Germ Cell Tumor.
- A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 Bladder cancer.
- Robotic Intracorporeal Orthotopic Ileal NeoBladder: Replicating Open Surgical Principles.
- Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis.
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
- Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
- Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
- Use of Nonabsorbable Staples for Urinary Diversion: A Step in the Wrong Direction.
- The value of extended transurethral resection of Bladder tumour (turbt) in the treatment of Bladder cancer.
- Adjuvant surgery in testicular Cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
- Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy.
- Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
- ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.
- Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node-Positive Disease after Radical Cystectomy.
- Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate Cancer with pathologically positive lymph nodes in the prostate-specific antigen ...
- SURVEILLANCE GUIDELINES BASED ON RECURRENCE PATTERNS AFTER RADICAL CYSTECTOMY FOR Bladder CANCER: THE CANADIAN Bladder CANCER NETWORK EXPERIENCE.
- Radical cystectomy with orthotopic neoBladder reconstruction following prior radical prostatectomy.
- Long-term Outcomes of Open Radical Retropubic Prostatectomy for Clinically Localized Prostate Cancer in the Prostate-specific Antigen Era.
- Factors influencing post-recurrence survival in Bladder cancer following radical cystectomy.
- Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery.
- Editorial comment.
- Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion.
- Colocalycostomy for repair of ureterojejunal Fistula.
- Stage-dependent differential expression of microRNAs in colorectal Cancer: potential role as markers of metastatic disease.
- Clinical nodal staging scores for Bladder cancer: a proposal for preoperative risk assessment.
- Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor.
- The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation.
- Management of residual mass in nonseminomatous germ cell tumors following chemotherapy.
- Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study.
- Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for Bladder cancer: a comparative study.
- Androgen-producing Testicular germ cell tumors.
- Improving selection of appropriate urinary diversion following radical cystectomy for Bladder cancer.
- Evolution in management of Testicular seminoma: population-based outcomes with selective utilization of active therapies.
- Distinctive morphology of Renal cell carcinomas in tuberous sclerosis.
- Factors influencing the choice of Urinary diversion in patients undergoing radical cystectomy.
- Non-risk-adapted surveillance for patients with stage I nonseminomatous Testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy.
- Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.
- Resection of the inferior vena cava without reconstruction for urologic malignancies.
- Open partial nephrectomy for pediatric renovascular hypertension.
Schools
Univ Of Ca
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
University of California Davis School of Medicine
Hospital
-
Keck Hospital of USC
Drug Facts
| NPI NUMBER | 1174546568 | |
| NPPES Provider LastName | DANESHMAND | |
| NPPES Provider FirstName | SIAMAK | |
| NPPES Provider ZIPCode | 90089 | |
| NPPES Provider State | CA | |
| Specialty Description | Urology | |
| Total Claim Count | 278.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 4.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174546568 |
| Last Name Of The Provider | DANESHMAND |
| First Name Of The Provider | SIAMAK |
| View All |
Similar Doctors
|
Dr. Mike M. Nguyen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. Rusnack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary E. Leach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard H. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Barba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ja-Hong Kim, MD |
|
|
Dr. Isla P. Garraway, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred Kuyt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karim Chamie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raed A. Azhar, MD |
|
|
Dr. Isuru S. Jayaratna, MD |
|
|
Dr. John A. Landsberger, DO |
|
|
Dr. Allan Pantuck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Adrian S. Fairey
This Doctor is OpenDoctor Recommended.
|